SCHEMBL5622693

SCHEMBL5622693

COc1ccc(N(C(C)C)S(=O)(=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.54
ALDH1A1 P00352 3/20 0.54
USP2 O75604 1/20 0.54
KEAP1 Q14145 4/20 0.53
PGR P06401 2/20 0.53
NFE2L2 Q16236 2/20 0.53
PKM P14618 1/20 0.52
GAA P10253 1/20 0.49
LMNA P02545 3/20 0.49
TP53 P04637 1/20 0.49
NR3C1 P04150 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HPGD P15428 1/20 0.46
HSD11B1 P28845 1/20 0.46
MDM4 O15151 1/20 0.46
MDM2 Q00987 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5333494 0.89 ALDH1A1 (0.58) ESR1ALDH1A1USP2KEAP1PGR
SCHEMBL5622597 0.85 ALDH1A1 (0.53) ALDH1A1USP2KEAP1PGRNFE2L2
SCHEMBL5623827 0.83 KEAP1 (0.51) ALDH1A1USP2KEAP1PGRNFE2L2
SCHEMBL5622125 0.83 PSEN1 (0.60) ALDH1A1USP2KEAP1PGRNFE2L2
SCHEMBL27927813 0.79 BMP1 (0.60) ALDH1A1GAAHPGDMDM4MDM2
SCHEMBL2119628 0.79 PSEN1 (0.52) ESR1ALDH1A1KEAP1PGRNR3C1
SCHEMBL5622356 0.78 PGR (0.79) ALDH1A1KEAP1PGRNFE2L2PKM
SCHEMBL5622395 0.78 ESR1 (0.83) ESR1ALDH1A1LMNAL3MBTL1HSD11B1
SCHEMBL5623334 0.77 KEAP1 (0.62) ALDH1A1KEAP1PGRNFE2L2LMNA
SCHEMBL2118315 0.77 PSEN1 (0.57) ALDH1A1PGRGAALMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021495-A1 SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021495-A1 SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR ESR1, ESR2, GPER1 ESR1 1/4885ALDH1A1 826/4885USP2 3000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.